Ono Pharmaceutical (Japan)

1.3k papers and 32.4k indexed citations i.

About

In recent decades, authors affiliated with Ono Pharmaceutical (Japan) have published 1.3k papers, which have received a total of 32.4k indexed citations. Scholars at this organization have produced 367 papers in Molecular Biology, 248 papers in Oncology and 204 papers in Pharmacology on the topics of Inflammatory mediators and NSAID effects (157 papers), Cancer Immunotherapy and Biomarkers (70 papers) and Asthma and respiratory diseases (68 papers). Their work is cited by papers focused on Molecular Biology (10.2k citations), Oncology (5.4k citations) and Pharmacology (4.7k citations). Authors at Ono Pharmaceutical (Japan) collaborate with scholars in Japan, United States and Italy and have published in prestigious journals including Nature, Science and Cell. Some of Ono Pharmaceutical (Japan)'s most productive authors include Takayuki Maruyama, Shuh Narumiya, Kazuhito Kawabata, Nobuo Katsube, Fumitaka Ushikubi, Yukihiko Sugimoto, Shinji Nakade, Katsuhiko Mikoshiba, Yoshiya Aze and Masaaki Toda.

In The Last Decade

Fields of papers published by authors at Ono Pharmaceutical (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Ono Pharmaceutical (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ono Pharmaceutical (Japan) at the time of their publication.

Countries citing scholars working at Ono Pharmaceutical (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Ono Pharmaceutical (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ono Pharmaceutical (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ono Pharmaceutical (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025